Gelonghui, March 14, 丨 Jinhuo Pharmaceutical Group (01110.HK) announced that the company will hold a board meeting on March 26, 2024 to review and approve the Group's audited annual results for the year ended December 31, 2023 and the proposed payment of a final dividend (if any), and to deal with any other matters.
金活医药集团(01110.HK)将于3月26日举行董事会会议以审批年度业绩
Jinhuo Pharmaceutical Group (01110.HK) will hold a board meeting on March 26 to approve the annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.